Q1 - 2022 Super Achiever's AwardQ2 - 2022 Elite Performers AwardQ3 - 2022 Elite Performers Award Q4 - 2022 Super Achievers AwardResponsible for driving diagnostic testing revenue in assigned territory. Actively collaborate with specialty representatives to ensure proper market penetration and coverage. Drove territory performance from 89% at hire to 104% of quota in first year. Super achievers recognition achieved in first year. Finished December 2022 at 110% of Quota and 106% for year 2022. Improved National Rank from 274 / 320 to 53 / 320 in 2022.

Amylase Technologies arose from the acquisition of Vine technologies. Vine Technologies recruited me to drive business development, logistics, operations and eventually open clinics throughout the Southeast. With the Amylase takeover I was offered the opportunity to remain as a team member of this startup venture. In my current role, I do everything necessary to bring the vision to life. My responsibilities include sales and building patient referrals through working with physicians in specialties including primary care, pain management, podiatry, vascular surgery, cardiology and endocrinology to name a few. I collaborate with and lead a team to develop marketing and business development strategies and tactics. Responsible for building clinical teams to serve our patients in both clinics and all staffing requirements including recruiting a Medical Director, hiring Nurse Practitioners for all clinics as well as Medical Assistants, front end receptionist. I work to develop policy and procedures for efficient clinic operations and workflow. Having managed and orchestrated all aspects necessary to open several clinics in the Georgia market, I have most recently been focused on patient acquisition and developing the necessary relationships within various specialties to drive referral business to our clinics while working with and training sales professionals in other markets. Having opened our first clinic in October of 2020 by January of '21 we had over 100 new patient referrals with approximately 80% conversion rate. I opened our second clinic in January of 2021 and by April '21 we enjoy a solid base of patients and are flourishing with referrals from multiple specialties.

Working in Oncology we have a history representing Invado Pharmaceuticals product NeutraSal for head and neck cancer patients. We specialize in providing laboratory consulting services and ancillary revenue streams to our clients specializing in Pain Management.

Founded unique business model in home healthcare providing both personal care for patients as well as residential maintenance / facilities management to help clients "age in place".

O.R. based clinical sales specialist of Implanted Medical Devices for spine stabilization

Promoted OxyContin into the Orthopedic, Orthopedic Spine and Neurosurgical Marketplace

Represented Astra-Zeneca product Nolvadex for new FDA approval for Breast Cancer risk reduction. Responsible for selling Nolvadex (Tamoxifen Citrate) into OB/GYN marketplaceReassigned to Abbott labs contract in October of 2000 as a result of Astra-Zeneca contract terminationHired directly by Abbott Labs in February of 2001